BeaconEquity.com announces the publication of an article covering recent news from Power3 Medical Products Inc. (OTCBB: PWRM), including the company’s clinical validation study of its NuroPro® blood serum showing successful diagnoses of different forms of Alzheimer's.
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m
In the article the author writes:
“Power3 Medical Products, a leading proteomics company, specializes in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases. The company is currently conducting a clinical validation study of its NuroPro® blood serum test for Alzheimer's and Parkinson's disease in collaboration with Dr. Marwan Sabbagh, the director of clinical research at the Cleo Roberts Center of Clinical Research at the Sun Health Research Institute in Sun City, Arizona.”
Power3’s NuroPro test shows successful diagnoses of different forms of Alzheimer's:
“NuroPro®, the first blood serum diagnostic test to be available for Alzheimer's disease, utilizes a panel of blood serum protein biomarkers to determine the probability that a patient has the said degenerative disease. … Power3 said its blood serum biomarker test for Alzheimer's disease showed successful diagnoses of different forms of Alzheimer's, a breakthrough seen to advance the diagnostic test's clinical usefulness.”
To read the entire article visit http://www.beaconequity.com/m
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s market news is one of the fastest growing small-cap blogs in the investment community. Beacon is the authority on research in the small-cap sector, and our analysts strive each day to find the stocks poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas.
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
